Nida Awadallah
Concepts (87)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Family Practice | 3 | 2021 | 451 | 1.080 |
Why?
| Internship and Residency | 3 | 2022 | 1052 | 0.880 |
Why?
| Education, Medical, Graduate | 3 | 2022 | 435 | 0.740 |
Why?
| General Surgery | 1 | 2022 | 156 | 0.710 |
Why?
| Mentoring | 1 | 2022 | 120 | 0.690 |
Why?
| Chronic Pain | 2 | 2022 | 248 | 0.690 |
Why?
| Carcinoma, Pancreatic Ductal | 2 | 2008 | 264 | 0.470 |
Why?
| Physicians | 1 | 2020 | 848 | 0.370 |
Why?
| Curriculum | 3 | 2022 | 925 | 0.350 |
Why?
| Pancreatic Neoplasms | 2 | 2008 | 878 | 0.340 |
Why?
| B7-1 Antigen | 1 | 2008 | 59 | 0.290 |
Why?
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2008 | 31 | 0.290 |
Why?
| Pain Management | 2 | 2022 | 319 | 0.280 |
Why?
| Bile Ducts | 1 | 2006 | 66 | 0.250 |
Why?
| Cholangitis, Sclerosing | 1 | 2006 | 68 | 0.240 |
Why?
| Tumor Suppressor Protein p53 | 1 | 2008 | 510 | 0.220 |
Why?
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2006 | 205 | 0.220 |
Why?
| Biomarkers, Tumor | 1 | 2008 | 1174 | 0.180 |
Why?
| Fellowships and Scholarships | 1 | 2022 | 270 | 0.150 |
Why?
| Ocular Hypertension | 2 | 2011 | 62 | 0.150 |
Why?
| Delphi Technique | 1 | 2020 | 220 | 0.150 |
Why?
| Glaucoma, Open-Angle | 2 | 2011 | 103 | 0.150 |
Why?
| Biopsy, Fine-Needle | 2 | 2008 | 66 | 0.140 |
Why?
| Pancreas | 2 | 2008 | 307 | 0.120 |
Why?
| Clinical Competence | 1 | 2022 | 1021 | 0.120 |
Why?
| Humans | 13 | 2022 | 129078 | 0.120 |
Why?
| Community Health Services | 1 | 2016 | 224 | 0.110 |
Why?
| Analgesics, Opioid | 1 | 2022 | 915 | 0.110 |
Why?
| Life Style | 1 | 2016 | 459 | 0.110 |
Why?
| Middle Aged | 6 | 2021 | 31024 | 0.100 |
Why?
| Practice Patterns, Physicians' | 1 | 2022 | 1284 | 0.100 |
Why?
| Pandemics | 1 | 2021 | 1516 | 0.100 |
Why?
| Aged | 5 | 2021 | 22068 | 0.100 |
Why?
| Surveys and Questionnaires | 2 | 2022 | 5365 | 0.100 |
Why?
| Exercise Therapy | 1 | 2016 | 406 | 0.100 |
Why?
| Family | 1 | 2016 | 651 | 0.100 |
Why?
| Prostaglandins F | 1 | 2011 | 17 | 0.090 |
Why?
| Cross-Sectional Studies | 1 | 2021 | 5036 | 0.090 |
Why?
| Primary Health Care | 2 | 2019 | 1671 | 0.080 |
Why?
| Pediatric Obesity | 1 | 2016 | 568 | 0.080 |
Why?
| Adult | 5 | 2021 | 35423 | 0.080 |
Why?
| V-Set Domain-Containing T-Cell Activation Inhibitor 1 | 1 | 2008 | 12 | 0.070 |
Why?
| Pilot Projects | 2 | 2016 | 1548 | 0.070 |
Why?
| Tissue Fixation | 1 | 2008 | 35 | 0.070 |
Why?
| Immunoenzyme Techniques | 1 | 2008 | 210 | 0.070 |
Why?
| Male | 6 | 2021 | 63248 | 0.070 |
Why?
| Gallstones | 1 | 2007 | 31 | 0.070 |
Why?
| Cloprostenol | 1 | 2007 | 13 | 0.070 |
Why?
| Timolol | 1 | 2007 | 14 | 0.070 |
Why?
| Lithotripsy | 1 | 2007 | 43 | 0.070 |
Why?
| Female | 6 | 2021 | 68274 | 0.070 |
Why?
| Endosonography | 1 | 2008 | 141 | 0.070 |
Why?
| Endoscopy, Digestive System | 1 | 2007 | 120 | 0.060 |
Why?
| Cholelithiasis | 1 | 2006 | 34 | 0.060 |
Why?
| Cholangiocarcinoma | 1 | 2006 | 76 | 0.060 |
Why?
| Bile Duct Neoplasms | 1 | 2006 | 99 | 0.060 |
Why?
| Retrospective Studies | 1 | 2022 | 14562 | 0.060 |
Why?
| United States | 1 | 2021 | 13992 | 0.060 |
Why?
| Neoplasm Staging | 1 | 2008 | 1286 | 0.060 |
Why?
| Antihypertensive Agents | 1 | 2007 | 487 | 0.050 |
Why?
| Predictive Value of Tests | 1 | 2008 | 1968 | 0.050 |
Why?
| Biopsy | 1 | 2006 | 1093 | 0.050 |
Why?
| Diagnosis, Differential | 1 | 2006 | 1435 | 0.050 |
Why?
| Reproducibility of Results | 1 | 2008 | 3047 | 0.040 |
Why?
| Follow-Up Studies | 2 | 2007 | 4927 | 0.040 |
Why?
| Aged, 80 and over | 2 | 2007 | 7063 | 0.040 |
Why?
| Community-Based Participatory Research | 1 | 2019 | 145 | 0.040 |
Why?
| Colorado | 2 | 2019 | 4445 | 0.040 |
Why?
| Prospective Studies | 2 | 2007 | 7070 | 0.040 |
Why?
| Behavior Control | 1 | 2016 | 15 | 0.030 |
Why?
| Biomarkers | 1 | 2008 | 3878 | 0.030 |
Why?
| Interviews as Topic | 1 | 2019 | 697 | 0.030 |
Why?
| Feasibility Studies | 1 | 2016 | 860 | 0.020 |
Why?
| Qualitative Research | 1 | 2019 | 1192 | 0.020 |
Why?
| Intraocular Pressure | 1 | 2011 | 297 | 0.020 |
Why?
| Blood Pressure | 1 | 2016 | 1746 | 0.020 |
Why?
| Practice Guidelines as Topic | 1 | 2016 | 1526 | 0.020 |
Why?
| Body Mass Index | 1 | 2016 | 2250 | 0.020 |
Why?
| Travoprost | 1 | 2007 | 13 | 0.020 |
Why?
| Dose-Response Relationship, Drug | 1 | 2011 | 1974 | 0.020 |
Why?
| Drug Combinations | 1 | 2007 | 327 | 0.020 |
Why?
| Recurrence | 1 | 2007 | 1013 | 0.010 |
Why?
| Clinical Trials as Topic | 1 | 2007 | 1005 | 0.010 |
Why?
| Child | 1 | 2016 | 20860 | 0.010 |
Why?
| Treatment Outcome | 1 | 2007 | 10256 | 0.010 |
Why?
| Animals | 1 | 2011 | 34708 | 0.010 |
Why?
| Adolescent | 1 | 2007 | 20241 | 0.000 |
Why?
|
|
Awadallah's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|